PRC

Universal Medical Announces 2023 Interim Results

Retrieved on: 
Thursday, August 24, 2023

HONG KONG, Aug 24, 2023 - (ACN Newswire) - Genertec Universal Medical Group Company Limited (the "Universal Medical" or "Company"; Stock Coke: 2666.HK) is pleased to announce the interim results for the six months ended 30 June 2023.

Key Points: 
  • HONG KONG, Aug 24, 2023 - (ACN Newswire) - Genertec Universal Medical Group Company Limited (the "Universal Medical" or "Company"; Stock Coke: 2666.HK) is pleased to announce the interim results for the six months ended 30 June 2023.
  • As at 30 June 2023, the number of consolidated medical institutions increased to 55 (including four Grade III Class A hospitals and 26 Grade II hospitals), with a capacity of 13,893 beds in total.
  • The performance contribution of this business segment mainly comes from providing hospital clients with life cycle management of medical equipment, medical devises sales and internet-based healthcare services.
  • In August 2023, the company acquired 85% equity interests of Casstar Medical Technology Wuxi Co., Ltd. ("Casstar") at the consideration of RMB467.5 million.

Cheetah Net Supply Chain Services Inc. Announces Preliminary First Half 2023 Results

Retrieved on: 
Monday, August 21, 2023

CHARLOTTE, North Carolina, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Cheetah Net Supply Chain Services Inc. (“Cheetah” or the “Company”) (Nasdaq CM: CTNT) announced today, based on a preliminary review, its unaudited revenue and results for the first half of 2023.

Key Points: 
  • CHARLOTTE, North Carolina, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Cheetah Net Supply Chain Services Inc. (“Cheetah” or the “Company”) (Nasdaq CM: CTNT) announced today, based on a preliminary review, its unaudited revenue and results for the first half of 2023.
  • The Company anticipates filing its Quarterly Report on Form 10-Q for the second quarter and six-month period ended June 30, 2023 by the deadline of September 14, 2023.
  • Unit volume and revenue were lower than the first half of 2022.
  • Cheetah expects to report a net profit for the first half of 2023, compared with a $0.5 million loss in the first half of 2022.

Yiren Digital Reports Second Quarter 2023 Financial Results

Retrieved on: 
Thursday, August 17, 2023

BEIJING, Aug. 17, 2023 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-driven one-stop select financial and lifestyle services platform in China, today announced its unaudited financial results for the quarter ended June 30, 2023.

Key Points: 
  • BEIJING, Aug. 17, 2023 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-driven one-stop select financial and lifestyle services platform in China, today announced its unaudited financial results for the quarter ended June 30, 2023.
  • Number of borrowers served in the second quarter of 2023 was 1,013,972 representing an increase of 16.2% from 872,235 in the first quarter of 2023 and compared to 556,094 in the same period of 2022.
  • "Despite a sequentially more challenging macro environment this quarter, we are pleased to report another quarter of solid financial results.," Ms. Na Mei, Chief Financial Officer, commented.
  • Total net revenue in the second quarter of 2023 was RMB1,324.2 million (US$182.6 million), representing an increase of 65% from RMB801.1 million in the second quarter of 2022.

Uxin Reports Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results

Retrieved on: 
Monday, August 14, 2023

BEIJING, Aug. 14, 2023 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced its unaudited financial results for the fourth quarter and fiscal year ended March 31, 2023.

Key Points: 
  • BEIJING, Aug. 14, 2023 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced its unaudited financial results for the fourth quarter and fiscal year ended March 31, 2023.
  • Mr. Feng Lin, Chief Financial Officer of Uxin, commented: "In fiscal year 2023, Uxin demonstrated resilience and ability to adapt to challenging circumstances.
  • Notably, we observed a recovery of our gross margin in the fourth quarter of fiscal year 2023, rebounding from 0.6% in the previous quarter to 2.3%.
  • Financial Results for the Fiscal Year Ended March 31, 2023
    Total revenues were RMB2,059.2 million (US$299.8 million) for the fiscal year ended March 31, 2023, an increase of 25.9% from RMB1,636.1 million in the prior fiscal year.

OrbusNeich FY2023 Interim Net Profit Triples to US$25.2 Million, Total Revenue Increases by 18.2% to US$81.4 Million

Retrieved on: 
Thursday, August 17, 2023

Gross profit rose by 22.1% to approximately US$58.3 million, with a gross profit margin of 71.6%.

Key Points: 
  • Gross profit rose by 22.1% to approximately US$58.3 million, with a gross profit margin of 71.6%.
  • As a result, profit attributable to the owners of the Company reached US$25.2 million, an increase of 213.3%, with a net profit margin of 30.9%.
  • Adjusted profit (non-HKFRS measure) (1) increased by 105.6% year-on-year to approximately US$25.4 million.
  • As at 30 June 2023, the Group was in a strong financial position with cash and bank balances of approximately US$239.0 million.

Essex Bio-Technology Posts Sound 2023 Interim Financial Results, Revenue Up 37.1%, Profit Up 22%

Retrieved on: 
Wednesday, August 16, 2023

HONG KONG, Aug 16, 2023 - (ACN Newswire) - Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced the interim results for the six months ended 30 June 2023 ("the period under review").

Key Points: 
  • HONG KONG, Aug 16, 2023 - (ACN Newswire) - Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced the interim results for the six months ended 30 June 2023 ("the period under review").
  • The profit of the Group increased by 22.0% to approximately HK$170 million as compared to approximately HK$139.2 million for the same period last year.
  • As of 30 June 2023, the Group had cash and cash equivalents of approximately HK$506 million (31 December 2022: approximately HK$543 million).
  • The Group's revenue is primarily made up of the segments of Ophthalmology and Surgical (wound care and healing).

Edvantage Group Announces its Business Update for First Three Quarters of FY2023

Retrieved on: 
Wednesday, July 26, 2023

HONG KONG, July 26, 2023 - (ACN Newswire) - Edvantage Group Holdings Limited ("Edvantage Group" or the "Group", stock code: 0382.HK), the largest private business higher and vocational education group in the Greater Bay Area, has announced its unaudited financial data and business update for the nine months ended 31 May 2023 (the "Period under Review").

Key Points: 
  • HONG KONG, July 26, 2023 - (ACN Newswire) - Edvantage Group Holdings Limited ("Edvantage Group" or the "Group", stock code: 0382.HK), the largest private business higher and vocational education group in the Greater Bay Area, has announced its unaudited financial data and business update for the nine months ended 31 May 2023 (the "Period under Review").
  • The increase in the Group's revenue was mainly attributable to the increase in the number of student enrolments and average tuition fees in all the PRC operating schools of the Group.
  • The number of full-time student enrolments of the Group was 87,068 for the nine months ended May 31, 2023.
  • Looking ahead, the Group will promote the high-quality development of vocational education, guided by national policies and the market.

IBO Technology Intends to Invest in Xingang Electronics

Retrieved on: 
Wednesday, July 5, 2023

Mr. Teng Da Cheng is the largest shareholder of Xingang Electronics, holding 49.9% equity interest.

Key Points: 
  • Mr. Teng Da Cheng is the largest shareholder of Xingang Electronics, holding 49.9% equity interest.
  • Xingang Electronics is a professional acoustic device and MEMS sensor product total solution provider and a leading high and new technology enterprise in the field of ECM microphone and MEMS sensor in the PRC.
  • Subject to the Group conducting financial, legal and business due diligence on Xingang Electronics and being satisfied with the results, the Group intends to acquire equity interest in Xingang Electronics held by Mr. Teng Da Cheng at a price with reference to valuation of not exceeding 20 times of the annual net profit of Xingang Electronics.
  • Xingang Electronics intends to establish and complete an offshore red chip structure in which Mr. Teng Da Cheng will hold an indirect shareholding in Xingang Electronics through an offshore holding company.

IBO Technology Appoints New Management

Retrieved on: 
Tuesday, July 4, 2023

Accelerates Development of Electronic Cigarette Business in the PRC, Actively Diversifies Development of Hardware Business

Key Points: 
  • Accelerates Development of Electronic Cigarette Business in the PRC, Actively Diversifies Development of Hardware Business
    HONG KONG, July 4, 2023 - (ACN Newswire) - IBO Technology Company Limited ("IBO Technology" or the "Company", together with its subsidiaries, the "Group"; stock code: 2708.HK) announces the appointment of Mr. Zhong Zhi Xiong and Mr. Jin Zi as co-chief executive officer and independent non-executive Director respectively, with effect from 3 July 2023.
  • Mr. Zhong Zhi Xiong has extensive industry knowledge and solid management experience in the electronic cigarette industry in the PRC, and he is also a top management talent in the relevant industry.
  • Mr. Jin Zi has extensive experience in asset management, global asset allocation, investment advisory and research on global macro and investment strategies.
  • Mr. LAI Tse Ming, Chairman and Executive Director of IBO Technology, said, "2023 is a golden period for the Group's diversified business development.

IBO Technology Announces FY2022/23 Annual Results

Retrieved on: 
Monday, July 3, 2023

HONG KONG, July 3, 2023 - (ACN Newswire) - IBO Technology Company Limited ("IBO Technology" or the "Company", together with its subsidiaries, the "Group"; stock code: 2708.HK) announces the audited consolidated annual results for the year ended 31 March 2023 (the "Year").

Key Points: 
  • HONG KONG, July 3, 2023 - (ACN Newswire) - IBO Technology Company Limited ("IBO Technology" or the "Company", together with its subsidiaries, the "Group"; stock code: 2708.HK) announces the audited consolidated annual results for the year ended 31 March 2023 (the "Year").
  • Internationally, the Russian-Ukrainian war and the trade tension between China and the United States posed a huge impact on the international situation.
  • Leveraging favorable policies, 5G technology has been developing in the PRC, and the industry application scenarios have been broadening, becoming a new engine in the construction of "Digital China".
  • Mr. LAI Tse Ming, Chairman and Executive Director of IBO Technology, said, "There are close connection and synergy among our three major business segments in the aspects of underlying technology, application technology, supply chain, project and business model.